{
    "medicine_id": "5e9e23f1957066aa2183eaa412057498f7d0d368",
    "platform_id": "DB00145",
    "metadata": {
        "name": "2 5 Travasol Amino Acid Injection With Electrolytes In 10 Dextrose 1 5 Solution",
        "composition": "1 5 Glycine",
        "clinical_particulars": {
            "therapeutic_indications": "Supplemental glycine may have antispastic activity Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti inflammatory activities",
            "contraindications": {
                "disease": "ORL RAT LD sub 50 sub 7930 mg kg SCU RAT LD sub 50 sub 5200 mg kg IVN RAT LD sub 50 sub 2600 mg kg ORL MUS LD sub 50 sub 4920 mg kg Doses of 1 gram daily are very well tolerated Mild gastrointestinal symptoms are infrequently noted In one study doses of 90 grams daily were also well tole",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Helps trigger the release of oxygen to the energy requiring cell making process Important in the manufacturing of hormones responsible for a strong immune system",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Digoxin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Lanatoside C"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Gitoformate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of adverse effects can be increased when Glycine is combined with Acetyldigoxin"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}